1073617-34-1

Basic information

• Product Name: 4-(3-chloro-5-(1,1-difluoro-2-hydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)-5,6-dihydropyridine-1(2H)-carboxamide
• Synonyms: 4-(3-chloro-5-(1,1-difluoro-2-hydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)-5,6-dihydropyridine-1(2H)-carboxamide
• CAS NO: 1073617-34-1
• Molecular Weight: 461.819
• Mol File: 1073617-34-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(3-chloro-5-(1,1-difluoro-2-hydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)-5,6-dihydropyridine-1(2H)-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-chloro-5-(1,1-difluoro-2-hydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)-5,6-dihydropyridine-1(2H)-carboxamide(1073617-34-1)
• EPA Substance Registry System: 4-(3-chloro-5-(1,1-difluoro-2-hydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)-5,6-dihydropyridine-1(2H)-carboxamide(1073617-34-1)

Safety Data

• Hazardous Substances Data: 1073617-34-1(Hazardous Substances Data)

Upstream product

• 120800-05-7 2,3-dichloro-5-acetylpyridine 
• 41667-95-2 5,6-dichloronicotinic acid 
• 1073617-96-5 tert-butyl 4-(3-chloro-5-(1,1-difluoro-2-hydroxyethyl)pyridin-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate 
• 1073617-95-4 2-(5,6-dichloropyridin-3-yl)-2,2-difluoroethyl acetate 
• 1073617-94-3 2-(5,6-dichloropyridin-3-yl)-2-oxoethyl acetate 
• 748129-66-0 2-bromo-1-(5,6-dichloropyridin-3-yl)ethanone 
• 54127-29-6 5,6-dichloronicotinoyl chloride 
• 162327-73-3 5,6-dichloro-N-methoxy-N-methyl-3-pyridinecarboxamide 
• 455-14-1 4-trifluoromethylphenylamine 
• 1073617-97-6 2-(5-chloro-6-(1,2,3,6-tetrahydropyridin-4-yl)pyridin-3-yl)-2,2-difluoroethanol hydrochloride 

Relevant articles and documents

TRPV1 ANTAGONISTS AND USES THEREOF

The invention relates to compounds of formula (I) and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof.